RACK1 regulates angiotensin II-induced contractions of SHR preglomerular vascular smooth muscle cells

American Journal of Physiology - Renal Physiology

Volumn 312, Issue 4, 2017, Pages F565-F576

  Zhu, Xiao ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin; Hypertension; Kidney; RACK1; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; NEUROPEPTIDE Y; PERTUSSIS TOXIN; RECEPTOR FOR ACTIVATED C KINASE 1; VIMENTIN; G-PROTEIN BETA GAMMA; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; PHOSPHOLIPASE C BETA; PLCB3 PROTEIN, RAT; PROTEIN BINDING; RACK1 PROTEIN, RAT; VASOCONSTRICTOR AGENT;

ADULT; ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; GENE SILENCING; GLOMERULUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HYPERTENSION; JUXTAGLOMERULAR APPARATUS; METABOLISM; MICROVASCULATURE; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; RNA INTERFERENCE; SMOOTH MUSCLE CELL; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; GTP-BINDING PROTEINS; HYPERTENSION; JUXTAGLOMERULAR APPARATUS; MALE; MICROVESSELS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEUROPEPTIDE Y; PHOSPHOLIPASE C BETA; PROTEIN BINDING; PROTEIN TRANSPORT; RATS, INBRED SHR; RATS, INBRED WKY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 85017014679     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00547.2016     Document Type: Article

References (53)

1. Adams DR, Ron D, Kiely PA. RACK1, A multifaceted scaffolding protein: Structure and function. Cell Commun Signal 9: 22, 2011. doi: 10.1186/1478-811X-9-22.
2. Anderson WP, Kett MM, Stevenson KM, Edgley AJ, Denton KM, Fitzgerald SM. Renovascular hypertension: structural changes in the renal vasculature. Hypertension 36: 648-652, 2000. doi: 10.1161/01.HYP.36.4.648.
3. +-ATPase in rat vascular smooth muscle cell grown in vitro. Am J Physiol Cell Physiol 244: C227-C233, 1983.
4. γ with RACK1 and other WD40 repeat proteins. J Mol Cell Cardiol 37: 399-406, 2004. doi: 10.1016/j.yjmcc.2004.04.019.
5. Cheng D, Zhu X, Barchiesi F, Gillespie DG, Dubey RK, Jackson EK. Receptor for activated protein kinase C1 regulates cell proliferation by modulating calcium signaling. Hypertension 58: 689-695, 2011. doi: 10.1161/HYPERTENSIONAHA.111.174508.
6. 1-36 in SHR vs. WKY preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 304: F770-F780, 2013. doi: 10.1152/ajprenal.00646.2012.
7. γ subunits. Annu Rev Pharmacol Toxicol 37: 167-203, 1997. doi: 10.1146/annurev.pharmtox.37.1.167.
8. η/PKD-mediated regulation of trans-Golgi network to plasma membrane transport. Biochem J 406: 157-165, 2007. doi: 10.1042/BJ20070359.
9. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 77: 75-197, 1997.
10. 1 binding to intracellular receptors for activated protein kinase C. Proc Natl Acad Sci U S A 91: 559-563, 1994. doi: 10.1073/pnas.91.2.559.
11. Do KH, Kim MS, Kim JH, Rhim B-Y, Lee WS, Kim CD, Bae SS. Angiotensin II-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway. Exp Mol Med 41: 569-576, 2009. doi: 10.3858/emm.2009.41.8.062.
12. Dubinion JH, Mi Z, Jackson EK. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 317: 1330-1336, 2006. doi: 10.1124/jpet.106.101279.
13. Dubinion JH, Mi Z, Zhu C, Gao L, Jackson EK. Pancreatic polypeptide- fold peptide receptors and angiotensin II-induced renal vasoconstriction. Hypertension 47: 545-551, 2006. doi: 10.1161/01.HYP.0000197033.54756.83.
14. ++and calmodulin. J Pharmacol Exp Ther 246: 479-484, 1988.
15. Feihl F, Liaudet L, Levy BI, Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res 78: 274-285, 2008. doi: 10.1093/cvr/cvn022.
16. Frank ED, Warren L. Aortic smooth muscle cells contain vimentin instead of desmin. Proc Natl Acad Sci USA 78: 3020-3024, 1981. doi: 10.1073/pnas.78.5.3020.
17. Frid MG, Moiseeva EP, Stenmark KR. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 75: 669-681, 1994. doi: 10.1161/01.RES.75.4.669.
18. 2-Adrenoceptors potentiate angiotensin IIand vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 305: 581-586, 2003. doi: 10.1124/jpet.102.047647.
19. Hao H, Ropraz P, Verin V, Camenzind E, Geinoz A, Pepper MS, Gabbiani G, Bochaton-Piallat ML. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 22: 1093-1099, 2002. doi: 10.1161/01.ATV.0000022407.91111.E4.
20. 1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417-428, 2007. doi: 10.1042/CS20060342.
21. Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation 9: 315-328, 2002. doi: 10.1080/713774078.
22. Jackson EK. Pertussis toxin normalizes enhanced renovascular responses to angiotensin II in spontaneously hypertensive rats. Life Sci 54: PL445-PL450, 1994. doi: 10.1016/0024-3205(94)90154-6.
23. 2-adrenoceptor interaction. J Pharmacol Exp Ther 314: 1109-1116, 2005. doi: 10.1124/jpet.105.086074.
24. 2-Adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension 51: 719-726, 2008. doi: 10.1161/HYPERTENSIONAHA.107.096297.
25. 2-adrenoceptors and angiotensin II receptors in genetic hypertension. Hypertension 38: 353-360, 2001. doi: 10.1161/01. HYP.38.3.353.
26. Jackson EK, Herzer WA, Vyas SJ, Kost CK Jr. Angiotensin II-induced renal vasoconstriction in genetic hypertension. J Pharmacol Exp Ther 291: 329-334, 1999.
27. Jackson EK, Kochanek SJ, Gillespie DG. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells. Hypertension 60: 757-764, 2012. doi: 10.1161/HYPERTENSIONAHA.112.196501.
28. 1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol 281: H581-H589, 2001.
29. Kost CK Jr, Herzer WA, Li P, Jackson EK. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269: 82-88, 1994.
30. Kost CK Jr, Herzer WA, Li P, Notoya M, Mizuhira V, Inagami T, Jackson EK. Angiotensin II-induced structural and functional alterations in spontaneously hypertensive rat kidney. Am J Physiol Renal Physiol 270: F229-F236, 1996.
31. Kost CK Jr, Herzer WA, Li PJ, Jackson EK. Pertussis toxin-sensitive G-proteins and regulation of blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 26: 449-455, 1999. doi: 10.1046/ j.1440-1681.1999.03058.x.
32. Kost CK Jr, Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension 21: 420-431, 1993. doi: 10.1161/01.HYP.21.4.420.
33. Kost CK Jr, Li P, Williams DS, Jackson EK. Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normoten- sive rats. J Cardiovasc Pharmacol 31: 854-861, 1998. doi: 10.1097/00005344-199806000-00008.
34. Kuppusamy M, Gomez-Sanchez EP, Gomez-Sanchez CE. Interaction of the mineralocorticoid receptor with RACK1 (Abstract). Hypertension 68: AP100, 2016.
35. Lai EY, Onozato ML, Solis G, Aslam S, Welch WJ, Wilcox CS. Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass. Hypertension 55: 983-989, 2010. doi: 10.1161/HYPERTENSIONAHA.109.149120.
36. Li P, Jackson EK. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 251: 909-921, 1989.
37. Matsumoto H, Moir LM, Oliver BG, Burgess JK, Roth M, Black JL, McParland BE. Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma. Thorax 62: 848-854, 2007. doi: 10.1136/thx.2006.070474.
38. Mochly-Rosen D, Khaner H, Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA 88: 3997-4000, 1991. doi: 10.1073/pnas.88.9.3997.
39. Mokkapatti R, Vyas SJ, Romero GG, Mi Z, Inoue T, Dubey RK, Gillespie DG, Stout AK, Jackson EK. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther 287: 223-231, 1998.
40. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004. doi: 10.1152/physrev.00041.2003.
41. q and Gβγ describes a simple two-state coincidence detector. Curr Biol 20: 1327-1335, 2010. doi: 10.1016/j.cub.2010.06.013.
42. Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide- specific phospholipase C. Physiol Rev 80: 1291-1335, 2000.
43. Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 45 Suppl A: A25-A32, 2007. doi: 10.1016/j.jvs.2007.03.001.
44. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol Renal Physiol 262: F236-F240, 1992.
45. Selbie LA, Hill SJ. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci 19: 87-93, 1998. doi: 10.1016/S0165-6147(97)01166-8.
46. Sklan EH, Podoly E, Soreq H. RACK1 has the nerve to act: structure meets function in the nervous system. Prog Neurobiol 78: 117-134, 2006. doi: 10.1016/j.pneurobio.2005.12.002.
47. Spiegelberg BD, Hamm HE. G betagamma binds histone deacetylase 5 (HDAC5) and inhibits its transcriptional co-repression activity. J Biol Chem 280: 41769-41776, 2005. doi: 10.1074/jbc.M504066200.
48. Thornton C, Tang KC, Phamluong K, Luong K, Vagts A, Nikanjam D, Yaka R, Ron D. Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization. J Biol Chem 279: 31357-31364, 2004. doi: 10.1074/jbc. M402316200.
49. Verrier JD, Jackson TC, Gillespie DG, Janesko-Feldman K, Bansal R, Goebbels S, Nave KA, Kochanek PM, Jackson EK. Role of CNPase in the oligodendrocytic extracellular 2=,3=-cAMP-adenosine pathway. Glia 61: 1595-1606, 2013. doi: 10.1002/glia.22523.
50. Vyas SJ, Jackson EK. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther 273: 768-777, 1995.
51. Worth NF, Rolfe BE, Song J, Campbell GR. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil Cytoskeleton 49: 130-145, 2001. doi: 10.1002/cm.1027.
52. q. Nat Cell Biol 14: 851-858, 2012. doi: 10.1038/ ncb2529.
53. 1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4. Am J Physiol Heart Circ Physiol 309: H1528-H1542, 2015. doi: 10.1152/ajpheart.00070.2015.